Search research articles
Contact Us
Filters
Showing results (41-50 of 82) with videos related to
Page
of 9
Sort By:
Clinical Pharmacokinetics
|
September 20, 2016
Towards a Model-Based Dose Recommendation for Doxorubicin in Children
Swantje Völler, Georg Hempel, Gudrun Würthwein, et al.
Journal of Lipid Research
|
October 26, 2013
An LC/MS/MS method for stable isotope dilution studies of β-carotene bioavailability, bioconversion, and vitamin A status in humans
Anthony Oxley, Philip Berry, Gordon A Taylor, et al.
Cancer Chemotherapy and Pharmacology
|
August 25, 2009
Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patients
Gareth J Veal, Michael Cole, Julie Errington, et al.
The Journal of Nutrition
|
August 12, 2016
Plasma Retinol Kinetics and β-Carotene Bioefficacy Are Quantified by Model-Based Compartmental Analysis in Healthy Young Adults with Low Vitamin A Stores
Michael H Green, Jennifer Lynn Ford, Anthony Oxley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2007
NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism
David Jamieson, Kerrie Wilson, Simon Pridgeon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2008
A phase I and pharmacokinetic study of ixabepilone in combination with Carboplatin in patients with advanced solid malignancies
Ruth Plummer, Penella Woll, David Fyfe, et al.
Cancer Chemotherapy and Pharmacology
|
May 25, 2006
An evaluation of thymidine phosphorylase as a means of preventing thymidine rescue from the thymidylate synthase inhibitor raltitrexed
Claire L Graham-Cole, Huw D Thomas, Gordon A Taylor, et al.
Pediatric Blood & Cancer
|
July 12, 2005
Potential clinical impact of taking multiple blood samples for research studies in paediatric oncology: how much do we really know?
Michael Cole, Alan V Boddy, Pamela Kearns, et al.
British Journal of Clinical Pharmacology
|
January 5, 2016
Development of a physiologically based pharmacokinetic model of actinomycin D in children with cancer
Christopher Walsh, Jennifer J Bonner, Trevor N Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2007
Pharmacokinetic investigation of imatinib using accelerator mass spectrometry in patients with chronic myeloid leukemia
Alan V Boddy, Julieann Sludden, Melanie J Griffin, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 82) with videos related to
Sort By:
Page
of 9
Clinical Pharmacokinetics
|
September 20, 2016
Towards a Model-Based Dose Recommendation for Doxorubicin in Children
Swantje Völler, Georg Hempel, Gudrun Würthwein, et al.
Journal of Lipid Research
|
October 26, 2013
An LC/MS/MS method for stable isotope dilution studies of β-carotene bioavailability, bioconversion, and vitamin A status in humans
Anthony Oxley, Philip Berry, Gordon A Taylor, et al.
Cancer Chemotherapy and Pharmacology
|
August 25, 2009
Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patients
Gareth J Veal, Michael Cole, Julie Errington, et al.
The Journal of Nutrition
|
August 12, 2016
Plasma Retinol Kinetics and β-Carotene Bioefficacy Are Quantified by Model-Based Compartmental Analysis in Healthy Young Adults with Low Vitamin A Stores
Michael H Green, Jennifer Lynn Ford, Anthony Oxley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2007
NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism
David Jamieson, Kerrie Wilson, Simon Pridgeon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2008
A phase I and pharmacokinetic study of ixabepilone in combination with Carboplatin in patients with advanced solid malignancies
Ruth Plummer, Penella Woll, David Fyfe, et al.
Cancer Chemotherapy and Pharmacology
|
May 25, 2006
An evaluation of thymidine phosphorylase as a means of preventing thymidine rescue from the thymidylate synthase inhibitor raltitrexed
Claire L Graham-Cole, Huw D Thomas, Gordon A Taylor, et al.
Pediatric Blood & Cancer
|
July 12, 2005
Potential clinical impact of taking multiple blood samples for research studies in paediatric oncology: how much do we really know?
Michael Cole, Alan V Boddy, Pamela Kearns, et al.
British Journal of Clinical Pharmacology
|
January 5, 2016
Development of a physiologically based pharmacokinetic model of actinomycin D in children with cancer
Christopher Walsh, Jennifer J Bonner, Trevor N Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2007
Pharmacokinetic investigation of imatinib using accelerator mass spectrometry in patients with chronic myeloid leukemia
Alan V Boddy, Julieann Sludden, Melanie J Griffin, et al.
Page
of 9